Alpha 2.0
Login Register
» Authors » P Guerra-Garcia

P Guerra-Garcia

Explore the profile of P Guerra-Garcia including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 37
Followers 0
Related Specialties
General Medicine
Oncology
Pharmacology
Top 10 Co-Authors
A Perez-Martinez
A Canete
C Solano
A M Borobia
C Ferreras
F Bautista
J Verdu-Amoros
A J Carcas
L Moreno
C Eguizabal
Published In
Clin Transl Oncol
EClinicalMedicine
Trials
Affiliations
Soon will be listed here.
Recent Articles
1.
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
Garcia-Garcia I, Guerra-Garcia P, Ferreras C, Borobia A, Carcas A, Queiruga-Parada J, et al.
Trials . 2021 Oct; 22(1):674. PMID: 34600562
Background: Moderate/severe cases of COVID-19 present a dysregulated immune system with T cell lymphopenia and a hyper-inflammatory state. This is a study protocol of an open-label, multi-center, double-arm, randomized, dose-finding...
2.
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
Perez-Martinez A, Mora-Rillo M, Ferreras C, Guerra-Garcia P, Pascual-Miguel B, Mestre-Duran C, et al.
EClinicalMedicine . 2021 Aug; 39:101086. PMID: 34405140
Background: Effective treatments are still needed to reduce the severity of symptoms, time of hospitalization, and mortality of COVID-19. SARS-CoV-2 specific memory T-lymphocytes obtained from convalescent donors recovered can be...
3.
The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)
Rubio-San-Simon A, Hladun Alvaro R, Juan Ribelles A, Castaneda Heredia A, Guerra-Garcia P, Verdu-Amoros J, et al.
Clin Transl Oncol . 2021 Jun; 23(12):2489-2496. PMID: 34076861
Purpose: Early phase trials are crucial in developing innovative effective agents for childhood malignancies. We report the activity in early phase paediatric oncology trials in Spain from its beginning to...
4.
Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)
Rubio-San-Simon A, Verdu-Amoros J, Hladun R, Juan-Ribelles A, Molero M, Guerra-Garcia P, et al.
Clin Transl Oncol . 2020 May; 23(1):183-189. PMID: 32472454
Purpose: The COVID-19 pandemic has forced healthcare stakeholders towards challenging decisions. We analyse the impact of the pandemic on the conduct of phase I-II trials for paediatric cancer during the...